Answers are grounded in this paper and cite their sources.
Case report illustrates unilateral gynecomastia from isoniazid in a patient with pulmonary TB, highlighting its rare occurrence.
Introduction: Gynecomastia is a rare but recognized adverse effect of isoniazid, which is a key component of anti-tubercular therapy (ATT). While bilateral gynecomastia is more commonly reported, unilateral presentation is exceedingly uncommon. A Case Report: 47-year-old male presented with a complaint of painful swelling over the right side of the chest for three weeks. Patient was on first line ATT for 2 months for treatment of microbiologically confirmed pulmonary TB. Local examination revealed a firm, tender, mobile, subareolar swelling approximately 3 cm in diameter over the right breast. Investigations were normal except for mildly elevated prolactin and glandular tissue hypertrophy in breast ultrasonography. Diagnosis of isoniazid induced gynecomastia was made, patient was reassured and pyridoxine dose was increased from 10mg/day to 40mg/day. At six-week follow-up, tenderness was resolved and swelling size reduced. Ison Conclusion : iazid-induced gynecomastia is a rarely reported adverse effect of a widely used drug in India. This case report serves to highlight the need for increased awareness.
No takes yet. Share an insight, caveat, or question.
Joy et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: